Azarnoff, D L <br/><br/>
Therapeutic implications of bioavailability.  [electronic resource] 

 -  Annual review of pharmacology and toxicology  1976 
 - 53-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0362-1642 
<br/><br/><label>Standard No.: </label>10.1146/annurev.pa.16.040176.000413  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Analgesics--metabolism<br/>Animals<br/>Anti-Bacterial Agents--metabolism<br/>Anti-Infective Agents--metabolism<br/>Anti-Inflammatory Agents--metabolism<br/>Anticoagulants--metabolism<br/>Anticonvulsants--metabolism<br/>Biological Availability<br/>Biopharmaceutics<br/>Cardiac Glycosides--metabolism<br/>Diuretics--metabolism<br/>Drug Therapy<br/>Humans<br/>Levodopa--metabolism<br/>Steroids--metabolism<br/>Thyroid Hormones--metabolism<br/>Vitamins--metabolism